Knight Therapeutics | GUD - EPS Earnings Per Share


Knight Therapeutics reported CAD0.13 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
0.02 -0.04 Nov/05
-0.03 0.02 -0.13 Aug/06
FY2027Q1 Mar/2026 0.13 -0.01 0.04 May/07




Eps Change Date
Acasti Pharma USD -0.06 0.15 Sep/2025
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
Aurora Cannabis CAD -0.13 0.51 Mar/2026
Avita Medical AUD -0.38 0 Dec/2025
Canopy Growth CAD -0.4 0.35 Mar/2026
Cronos Group USD 0.09 0.05 Jun/2026
Dianthus Therapeutics USD -0.85 0.58 Mar/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
IQVIA Holdings USD 3.15 0.25 Jun/2026
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Moderna USD -1.97 1.43 Jun/2026
Omeros USD -1.12 0.37 Jun/2024
Organigram Holdings CAD -0.01 0.15 Mar/2026
Organon & Co USD 0.4 0.31 Jun/2026
Revvity USD 1.41 0.35 Jun/2026
Tectonic Therapeutic USD -1.34 0.32 Mar/2026
Tilray USD -0.41 0.4 Dec/2025
Viatris USD 0.69 0.1 Jun/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026